1. Home
  2. LEU vs PLSE Comparison

LEU vs PLSE Comparison

Compare LEU & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEU
  • PLSE
  • Stock Information
  • Founded
  • LEU 1998
  • PLSE 2014
  • Country
  • LEU United States
  • PLSE United States
  • Employees
  • LEU N/A
  • PLSE N/A
  • Industry
  • LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • PLSE Medical/Dental Instruments
  • Sector
  • LEU Industrials
  • PLSE Health Care
  • Exchange
  • LEU Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • LEU 1.3B
  • PLSE 1.3B
  • IPO Year
  • LEU 1998
  • PLSE 2016
  • Fundamental
  • Price
  • LEU $63.03
  • PLSE $16.73
  • Analyst Decision
  • LEU Strong Buy
  • PLSE
  • Analyst Count
  • LEU 5
  • PLSE 0
  • Target Price
  • LEU $143.40
  • PLSE N/A
  • AVG Volume (30 Days)
  • LEU 542.6K
  • PLSE 217.1K
  • Earning Date
  • LEU 05-06-2025
  • PLSE 03-27-2025
  • Dividend Yield
  • LEU N/A
  • PLSE N/A
  • EPS Growth
  • LEU N/A
  • PLSE N/A
  • EPS
  • LEU 4.47
  • PLSE N/A
  • Revenue
  • LEU $442,000,000.00
  • PLSE N/A
  • Revenue This Year
  • LEU $2.45
  • PLSE N/A
  • Revenue Next Year
  • LEU $17.65
  • PLSE N/A
  • P/E Ratio
  • LEU $14.10
  • PLSE N/A
  • Revenue Growth
  • LEU 38.04
  • PLSE N/A
  • 52 Week Low
  • LEU $33.51
  • PLSE $6.60
  • 52 Week High
  • LEU $122.95
  • PLSE $25.00
  • Technical
  • Relative Strength Index (RSI)
  • LEU 33.28
  • PLSE 47.07
  • Support Level
  • LEU $60.65
  • PLSE $15.29
  • Resistance Level
  • LEU $68.19
  • PLSE $17.85
  • Average True Range (ATR)
  • LEU 4.27
  • PLSE 1.08
  • MACD
  • LEU -0.74
  • PLSE 0.13
  • Stochastic Oscillator
  • LEU 12.22
  • PLSE 58.97

About LEU Centrus Energy Corp.

Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: